Robotic CABG Shows Favorable Outcomes Versus Minimally Invasive and Conventional TechniquesRobotic surgery shows potential benefits for heart bypass patients

This network meta-analysis pooled data from 779,773 patients undergoing coronary artery bypass grafting (CABG) to compare conventional (C-CABG), minimally invasive (MI-CABG), and robotic (R-CABG) approaches, including their sub-techniques. The analysis examined mortality, complete revascularization, resource utilization outcomes, and major complications. The evidence base was predominantly observational, and the authors frame the findings as hypothesis-generating rather than definitive.

Revascularization rates were broadly comparable across the three main techniques. The one notable exception involved the port-access sub-technique (PA-CABG), which achieved a significantly higher revascularization rate than conventional on-pump CABG (C-ONCAB). This suggests that specific minimally invasive sub-techniques may differ meaningfully from one another, and that grouping them under a single MI-CABG label could obscure clinically relevant variation.

For resource utilization and mortality, R-CABG demonstrated more favorable outcomes than both MI-CABG and C-CABG, with shorter ICU stays, shorter overall hospital stays, lower mortality, and reduced ventilation time. These findings are consistent with the smaller incisions and greater precision associated with robotic assistance, though the observational nature of the underlying data leaves room for selection bias and confounding by center expertise.

Complication profiles also favored R-CABG. Wound infection, cerebrovascular accident, and renal failure occurred less frequently with the robotic approach than with MI-CABG or C-CABG. Non-sinus rhythm was less common with both R-CABG and MI-CABG relative to C-CABG, suggesting a possible advantage for minimally invasive strategies in avoiding postoperative arrhythmia.

Reoperation rates told a different story: MI-CABG carried the highest reoperation rate among the techniques compared. This counterpoint is important for clinicians weighing the trade-offs of minimally invasive approaches, since reduced surgical trauma may come at the cost of greater need for reintervention in some patients.

Safety data reflected the complication outcomes above, with wound infection, cerebrovascular accident, renal failure, and non-sinus rhythm identified as the principal adverse events of interest. Serious adverse events, discontinuations, and tolerability were not reported, limiting the ability to fully characterize the safety profile across techniques.

The principal limitation is the reliance on predominantly observational data, which precludes causal inference and leaves the results vulnerable to confounding. Follow-up duration, funding sources, and conflicts of interest were not reported, and certainty of evidence was not graded. These gaps constrain interpretation and underscore the need for randomized comparisons.

For practice, R-CABG appears promising across mortality, recovery, and complication outcomes, but the findings should not be read as establishing superiority of robotic or any specific sub-technique. Clinicians should treat these results as a hypothesis-generating framework to inform shared decision-making and to guide the design of adequately powered randomized trials that can confirm whether the observed advantages are attributable to the technique itself.